Clinical Trial Update: Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial investigating hyperpolarized carbon-13 alpha-ketoglutarate imaging in IDH-mutant glioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• Idh-mutant Glioma

Drugs mentioned

• Hyperpolarized Carbon-13 Alpha-ketoglutarate imaging (carbon-13 alpha-ketoglutarate imaging agent)

Snippet

Sponsor: Robert Bok, MD, PhD | Conditions: Adult Gliomas, Mixed | EARLY_Phase 1 | Status: RECRUITING